159 related articles for article (PubMed ID: 7509142)
1. Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs.
Thormar H; Balzarini J; Holy A; Jindrich J; Rosenberg I; Debyser Z; Desmyter J; De Clercq E
Antimicrob Agents Chemother; 1993 Dec; 37(12):2540-4. PubMed ID: 7509142
[TBL] [Abstract][Full Text] [Related]
2. Marked inhibitory activity of masked aryloxy aminoacyl phosphoramidate derivatives of dideoxynucleoside analogues against visna virus infection.
Balzarini J; Cahard D; Wedgwood O; Salgado A; Velázquez S; Yarnold CJ; De Clercq E; McGuigan C; Thormar H
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):296-302. PubMed ID: 9525429
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of visna virus replication and cytopathic effect in sheep choroid plexus cell cultures by selected anti-HIV agents.
Thormar H; Balzarini J; Debyser Z; Witvrouw M; Desmyter J; De Clercq E
Antiviral Res; 1995 May; 27(1-2):49-57. PubMed ID: 7486958
[TBL] [Abstract][Full Text] [Related]
4. Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides.
Frank KB; McKernan PA; Smith RA; Smee DF
Antimicrob Agents Chemother; 1987 Sep; 31(9):1369-74. PubMed ID: 2445282
[TBL] [Abstract][Full Text] [Related]
5. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
Hao Z; Cooney DA; Hartman NR; Perno CF; Fridland A; DeVico AL; Sarngadharan MG; Broder S; Johns DG
Mol Pharmacol; 1988 Oct; 34(4):431-5. PubMed ID: 2459590
[TBL] [Abstract][Full Text] [Related]
6. Phosphonoformate inhibition of visna virus replication.
Sundquist B; Larner E
J Virol; 1979 Jun; 30(3):847-51. PubMed ID: 90168
[TBL] [Abstract][Full Text] [Related]
7. Treatment of visna virus infection in lambs with the acyclic nucleoside phosphonate analogue 9-(2-phosphonylmethoxyethyl)adenine (PMEA).
Thormar H; Georgsson G; Gunnarsson E; Naesens L; Torsteinsdóttir S; Balzarini J; De Clercq E
Antivir Chem Chemother; 1998 May; 9(3):245-52. PubMed ID: 9875403
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
[TBL] [Abstract][Full Text] [Related]
9. Maedi-visna virus, a model for in vitro testing of potential anti-HIV drugs.
Salvatori D; Vincenzetti S; Maury G; Gosselin G; Gaubert G; Vita A
Comp Immunol Microbiol Infect Dis; 2001 Apr; 24(2):113-22. PubMed ID: 11247044
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives.
Balzarini J
Pharm World Sci; 1994 Apr; 16(2):113-26. PubMed ID: 8032337
[TBL] [Abstract][Full Text] [Related]
11. Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1.
Salvatori D; Volpini R; Vincenzetti S; Vita A; Costanzi S; Lambertucci C; Cristalli G; Vittori S
Bioorg Med Chem; 2002 Sep; 10(9):2973-80. PubMed ID: 12110319
[TBL] [Abstract][Full Text] [Related]
12. AZT inhibits Visna/maedi virus-induced apoptosis.
Bellet V; Duval R; Delebassée S; Cook-Moreau J; Bosgiraud C
Arch Virol; 2004 Mar; 149(3):583-601. PubMed ID: 14991445
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides.
Herdewijn P; Balzarini J; Baba M; Pauwels R; Van Aerschot A; Janssen G; De Clercq E
J Med Chem; 1988 Oct; 31(10):2040-8. PubMed ID: 3172142
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of 9-(2-phosphonylmethoxyethyl)adenine on visna virus infection in lambs: a model for in vivo testing of candidate anti-human immunodeficiency virus drugs.
Thormar H; Georgsson G; Pálsson PA; Balzarini J; Naesens L; Torsteinsdóttir S; De Clercq E
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3283-7. PubMed ID: 7724553
[TBL] [Abstract][Full Text] [Related]
15. [Evidence for the production of a fusion factor during in vitro infection of sheep choroid plexus cells by visna virus].
Pautrat G; Filippi P
C R Seances Soc Biol Fil; 1979; 173(4):811-7. PubMed ID: 230888
[TBL] [Abstract][Full Text] [Related]
16. Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds.
Balzarini J; Herdewijn P; De Clercq E
J Biol Chem; 1989 Apr; 264(11):6127-33. PubMed ID: 2539371
[TBL] [Abstract][Full Text] [Related]
17. Anti-human immunodeficiency virus type 1 activities of dideoxynucleoside phosphotriester derivatives in primary monocytes/macrophages.
Thumann-Schweitzer C; Gosselin G; Périgaud C; Benzaria S; Girardet JL; Lefebvre I; Imbach JL; Kirn A; Aubertin AM
Res Virol; 1996; 147(2-3):155-63. PubMed ID: 8901435
[TBL] [Abstract][Full Text] [Related]
18. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Webb DS; Hao Z; Mitsuya H; Johns DG; Broder S
J Exp Med; 1989 Mar; 169(3):933-51. PubMed ID: 2538549
[TBL] [Abstract][Full Text] [Related]
19. Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology.
Barber SA; Bruett L; Douglass BR; Herbst DS; Zink MC; Clements JE
J Virol; 2002 Jan; 76(2):817-28. PubMed ID: 11752171
[TBL] [Abstract][Full Text] [Related]
20. Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine.
Balzarini J; Holy A; Jindrich J; Naesens L; Snoeck R; Schols D; De Clercq E
Antimicrob Agents Chemother; 1993 Feb; 37(2):332-8. PubMed ID: 8452366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
